View More Recent Stories

Mar 17, 2025 01:48PM Guggenheim Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX), Top Pick
Mar 12, 2025 11:30AM TD Cowen: 'Moonlake Immunotherapeutics (MLTX) is a Europe Best Idea'
Dec 12, 2024 01:18PM Clear Street Starts Moonlake Immunotherapeutics (MLTX) at Buy
Oct 15, 2024 06:32AM H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
Sep 12, 2024 08:55AM TD Cowen Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
Sep 12, 2024 07:47AM H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
Sep 12, 2024 05:16AM BTIG Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
Aug 26, 2024 06:03AM Wolfe Research Downgrades Moonlake Immunotherapeutics (MLTX) to Peerperform
Jul 1, 2024 06:37AM H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
Jun 24, 2024 04:10PM Oppenheimer Starts Moonlake Immunotherapeutics (MLTX) at Outperform
Jun 10, 2024 07:02AM MoonLake Immunotherapeutics (MLTX) Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody sonelokimab in Psoriatic Arthritis
View More Recent Stories